X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5396) 5396
Publication (292) 292
Book Review (52) 52
Book Chapter (25) 25
Magazine Article (10) 10
Book / eBook (5) 5
Conference Proceeding (5) 5
Dissertation (3) 3
Newsletter (3) 3
Web Resource (2) 2
Data Set (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3807) 3807
animals (1986) 1986
male (1372) 1372
index medicus (1223) 1223
heparin - pharmacology (1212) 1212
antithrombins - pharmacology (1182) 1182
hematology (1123) 1123
female (1069) 1069
thrombin (965) 965
blood coagulation - drug effects (877) 877
heparin (834) 834
peripheral vascular disease (763) 763
anticoagulants - pharmacology (761) 761
pharmacology & pharmacy (706) 706
thrombin - antagonists & inhibitors (700) 700
antithrombin (665) 665
antithrombin iii - metabolism (658) 658
thrombin - metabolism (652) 652
antithrombin-iii (608) 608
adult (607) 607
anticoagulants (603) 603
antithrombin iii - pharmacology (600) 600
kinetics (590) 590
biochemistry & molecular biology (584) 584
middle aged (582) 582
rats (541) 541
antithrombin iii (477) 477
coagulation (474) 474
antithrombins - therapeutic use (465) 465
aged (447) 447
dose-response relationship, drug (419) 419
thrombosis (396) 396
hirudins - pharmacology (371) 371
antithrombin iii - analysis (369) 369
factor xa inhibitors (363) 363
anticoagulants - therapeutic use (349) 349
time factors (340) 340
antithrombins - metabolism (329) 329
partial thromboplastin time (329) 329
binding sites (323) 323
activation (322) 322
rabbits (313) 313
dabigatran (312) 312
molecular sequence data (311) 311
blood coagulation (295) 295
structure-activity relationship (295) 295
antithrombins - chemistry (291) 291
plasma (290) 290
protein binding (284) 284
amino acid sequence (283) 283
in vitro techniques (280) 280
blood coagulation tests (278) 278
mice (277) 277
recombinant proteins - pharmacology (276) 276
heparin - metabolism (269) 269
molecular weight (268) 268
cattle (267) 267
factor xa (261) 261
binding (249) 249
platelet aggregation - drug effects (246) 246
anticoagulant (242) 242
antithrombins (241) 241
fibrinolytic agents - pharmacology (241) 241
antithrombins - administration & dosage (239) 239
disease models, animal (239) 239
cardiac & cardiovascular systems (236) 236
heparin - therapeutic use (235) 235
analysis (233) 233
antithrombins - adverse effects (233) 233
thrombin - pharmacology (229) 229
chemistry, medicinal (223) 223
inhibition (222) 222
surgery (219) 219
fibrinolysis - drug effects (214) 214
warfarin (210) 210
fibrinogen - metabolism (205) 205
venous thromboembolism (204) 204
glycosaminoglycans (201) 201
blood (199) 199
cells, cultured (198) 198
molecular-weight heparin (198) 198
fibrinolysis (194) 194
blood platelets - drug effects (193) 193
hemorrhage - chemically induced (191) 191
anticoagulants - chemistry (189) 189
disseminated intravascular coagulation (189) 189
thrombosis - prevention & control (189) 189
models, molecular (186) 186
hirudin (182) 182
administration, oral (179) 179
heparin - chemistry (178) 178
tissue factor (178) 178
anticoagulants - adverse effects (174) 174
recombinant proteins - therapeutic use (174) 174
swine (174) 174
endothelial-cells (173) 173
anticoagulants - administration & dosage (172) 172
peptide fragments - pharmacology (172) 172
treatment outcome (171) 171
mechanism (170) 170
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5150) 5150
German (73) 73
Russian (57) 57
Japanese (49) 49
French (46) 46
Chinese (17) 17
Italian (15) 15
Polish (7) 7
Spanish (6) 6
Swedish (5) 5
Czech (3) 3
Danish (3) 3
Hungarian (3) 3
Arabic (1) 1
Dutch (1) 1
Norwegian (1) 1
Portuguese (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2014, Volume 64, Issue 11, pp. 1128 - 1139
Abstract Background Non–vitamin K oral anticoagulants (NOACs) do not require routine laboratory monitoring. However, laboratory measurement may be desirable in... 
Cardiovascular | Internal Medicine | dabigatran | rivaroxaban | monitoring | laboratory | apixaban | MEASURING RIVAROXABAN | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | DABIGATRAN CONCENTRATIONS | PROTHROMBIN TIME | PARTIAL THROMBOPLASTIN TIME | COAGULATION ASSAYS | IN-VITRO | FACTOR-XA INHIBITOR | PLASMA-CONCENTRATIONS | INTERNATIONAL NORMALIZED RATIO | Anticoagulants - administration & dosage | Humans | Antithrombins - administration & dosage | Thiophenes - administration & dosage | Dabigatran | Factor Xa Inhibitors - administration & dosage | Antithrombins - pharmacology | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | beta-Alanine - pharmacology | Factor Xa Inhibitors - pharmacology | beta-Alanine - analogs & derivatives | Pyrazoles - pharmacology | Administration, Oral | Morpholines - administration & dosage | beta-Alanine - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Pyrazoles - administration & dosage | Partial Thromboplastin Time | Anticoagulants - pharmacology | Benzimidazoles - pharmacology | Drug Monitoring | Pyridones - pharmacology | Measurement | Anticoagulants (Medicine) | Vitamins | Studies | Anticoagulants | Plasma | Bibliographic literature | Laboratories | Drug therapy | Drug dosages | Bone surgery
Journal Article
European Heart Journal, ISSN 0195-668X, 02/2013, Volume 34, Issue 7, pp. 489 - 500
Novel oral anticoagulants that directly inhibit thrombin (dabigatran) or factor Xa (rivaroxaban, apixaban) are currently available for prevention of venous... 
Novel oral anticoagulants | Bleeding | Management | RECOMBINANT FACTOR-VIIA | CARDIAC & CARDIOVASCULAR SYSTEMS | DIRECT THROMBIN INHIBITOR | RANDOMIZED EVALUATION | INTRACRANIAL HEMORRHAGE | ACTIVATED FACTOR-VII | FACTOR-XA INHIBITOR | DABIGATRAN ETEXILATE | VENOUS THROMBOEMBOLISM | PROTHROMBIN COMPLEX CONCENTRATE | NONVALVULAR ATRIAL-FIBRILLATION | Plasma | Anticoagulants - administration & dosage | Factor Xa Inhibitors | Thiophenes - adverse effects | Humans | Antithrombins - administration & dosage | Hemorrhage - prevention & control | Thiophenes - administration & dosage | Dabigatran | Antithrombins - pharmacology | Pyridones - administration & dosage | Rivaroxaban | Benzimidazoles - administration & dosage | Platelet Aggregation Inhibitors - administration & dosage | beta-Alanine - pharmacology | Renal Insufficiency - complications | Benzimidazoles - adverse effects | Drug Therapy, Combination | beta-Alanine - analogs & derivatives | Morpholines - adverse effects | Pyrazoles - adverse effects | Pyrazoles - pharmacology | Acute Disease | beta-Alanine - adverse effects | Administration, Oral | Morpholines - administration & dosage | Risk Factors | beta-Alanine - administration & dosage | Morpholines - pharmacology | Thiophenes - pharmacology | Anticoagulants - adverse effects | Pyrazoles - administration & dosage | Anticoagulants - pharmacology | Antithrombins - adverse effects | Blood Coagulation Tests | Benzimidazoles - pharmacology | Aged | Hemostatics - therapeutic use | Pyridones - adverse effects | Pyridones - pharmacology | Renal Dialysis
Journal Article
Journal Article
Clinical Pharmacokinetics, ISSN 0312-5963, 8/2019, Volume 58, Issue 8, pp. 1015 - 1028
Unfractionated heparin (UFH) is a commonly used anticoagulant therapy for the acute treatment and prevention of thrombosis. Its short duration of action,... 
Pharmacotherapy | Internal Medicine | Medicine & Public Health | Pharmacology/Toxicology | DERMATAN SULFATE | FACTOR-XIA | ANTITHROMBIN-III | THROMBIN INHIBITION | PHARMACOLOGY & PHARMACY | CARDIOPULMONARY BYPASS | AFFINITY-CHROMATOGRAPHY | BINDING-PROPERTIES | COFACTOR-II | FACTOR-XA | FACTOR PATHWAY INHIBITOR
Journal Article
Journal Article
American Journal of Hypertension, ISSN 0895-7061, 2/2015, Volume 28, Issue 2, pp. 182 - 189
Journal Article
Journal Article
European Heart Journal, ISSN 0195-668X, 01/2017, Volume 38, Issue 1, pp. 38 - 50
Journal Article
BRITISH JOURNAL OF HAEMATOLOGY, ISSN 0007-1048, 12/2013, Volume 163, Issue 5, pp. 666 - 673
There is increasing recognition that thrombotic complications may occur in patients with cirrhosis, and literature on antithrombotic treatment in these... 
anticoagulants | antithrombin | coagulation | anti‐Xa assay | cirrhosis | Anti-Xa assay | Anticoagulants | Cirrhosis | Antithrombin | Coagulation | anti-Xa assay | THROMBOSIS | MOLECULAR-WEIGHT HEPARIN | LIVER-DISEASE | HEMATOLOGY | HEMOSTASIS | Thiophenes - therapeutic use | Heparin, Low-Molecular-Weight - pharmacology | Polysaccharides - blood | Factor Xa Inhibitors | beta-Alanine - blood | Humans | Middle Aged | Heparin - therapeutic use | Male | Dabigatran | Drug Monitoring - methods | Morpholines - blood | Heparin, Low-Molecular-Weight - therapeutic use | Thiophenes - blood | Thrombophilia - etiology | Antithrombins - pharmacology | Rivaroxaban | Heparin, Low-Molecular-Weight - blood | Sensitivity and Specificity | beta-Alanine - pharmacology | Prothrombin - antagonists & inhibitors | Female | beta-Alanine - analogs & derivatives | Benzimidazoles - blood | Heparin - pharmacology | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Polysaccharides - therapeutic use | Liver Cirrhosis - drug therapy | Liver Cirrhosis - complications | beta-Alanine - therapeutic use | False Negative Reactions | Morpholines - pharmacology | Thiophenes - pharmacology | Liver Cirrhosis - blood | Polysaccharides - pharmacology | Anticoagulants - blood | Diagnostic Tests, Routine | Blood Coagulation - drug effects | Thrombophilia - blood | Anticoagulants - pharmacology | Antithrombins - blood | Blood Coagulation Tests | Heparin - blood | Benzimidazoles - pharmacology | Liver cirrhosis | Anticoagulants (Medicine)
Journal Article
Best Practice & Research: Clinical Haematology, ISSN 1521-6926, 2012, Volume 25, Issue 3, pp. 351 - 360
The standard effective treatment of venous and arterial thromboembolism includes unfractionated and low-molecular weight heparin as well as warfarin, which... 
Hematology, Oncology and Palliative Medicine | new anticoagulants | thromboembolism | factor Xa inhibitors | direct thrombin inhibitors | PREDICTING STROKE | STROKE PREVENTION | DEEP-VEIN THROMBOSIS | KNEE REPLACEMENT | VENOUS THROMBOEMBOLISM | DABIGATRAN ETEXILATE | MOLECULAR-WEIGHT HEPARIN | ANTITHROMBOTIC THERAPY | DOUBLE-BLIND | NONVALVULAR ATRIAL-FIBRILLATION | HEMATOLOGY | Thiophenes - therapeutic use | Heparin, Low-Molecular-Weight - pharmacology | Pyrazoles - therapeutic use | Factor Xa Inhibitors | Humans | Thrombin - antagonists & inhibitors | Azetidines - pharmacology | Dabigatran | Thiazoles - therapeutic use | Heparin, Low-Molecular-Weight - therapeutic use | Warfarin - pharmacology | Warfarin - therapeutic use | Antithrombins - pharmacology | Rivaroxaban | Clinical Trials, Phase III as Topic | Thromboembolism - drug therapy | Morpholines - therapeutic use | Benzimidazoles - therapeutic use | Pyrazoles - pharmacology | Pyridines - therapeutic use | Antithrombins - therapeutic use | Morpholines - pharmacology | Thiophenes - pharmacology | Anticoagulants - therapeutic use | Azetidines - therapeutic use | Anticoagulants - pharmacology | Benzimidazoles - pharmacology | Pyridines - pharmacology | Pyridones - therapeutic use | Thiazoles - pharmacology | Benzylamines - pharmacology | Benzylamines - therapeutic use | Pyridones - pharmacology
Journal Article
Journal Article
American journal of clinical pathology, ISSN 0002-9173, 2014, Volume 141, Issue 5, pp. 665 - 674
Objectives: The activated partial thromboplastin time (aPTT) test has been used for years to monitor parenteral direct thrombin inhibitors (DTIs) and... 
aPTT | Argatroban | Bivalirudin | Dabigatran | Ecarin | Monitoring | Thrombin time | INDUCED CLOTTING TIME | ECARIN CHROMOGENIC ASSAY | PATHOLOGY | COAGULATION ASSAYS | HEPARIN | PLASMA | THERAPY | DABIGATRAN ETEXILATE | ORAL ANTICOAGULANTS | HEALTHY-INDIVIDUALS | Thromboplastin - pharmacology | Humans | Thrombin - antagon